LIFMIOR Canadian Trademark Information

On Monday, June 21, 2010, a canadian trademark registration was filed for LIFMIOR by Pfizer Products Inc. a Connect *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1485995. The current status of this trademark filing is Interruption of proceeding. The correspondent listed for LIFMIOR is BERESKIN & PARR LLP/S.E.N.C.R. of *********, **********, ***** **** The LIFMIOR trademark is filed in the description of Pharmaceutical preparations for the treatment of cardiovascular disease; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, and smoking habits or addictions; neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy; genitourinary diseases, namely urological diseases, inflammatory pelvic diseases; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; allergies; diabetes; hypertension; erectile dysfunction; sexual dysfunction; metabolic diseases and disorders, namely growth and thyroid disorders; hemolytic diseases and disorders; cancer; migraines; pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain; obesity; inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; the respiratory system; infectious diseases, namely respiratory infections, eye infections; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS); viral diseases and disorders, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); stroke; psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, cognitive disorders, schizophrenia, depression; substance abuse disorders, namely alcoholism and drug addiction; carpal tunnel syndrome; varicose veins; dental and oral diseases; osteoporosis; arthritis; multiple sclerosis; yeast infections; prostate disorders; pulmonary disorders; and insomnia. Pharmaceutical preparations for use in oncology; dermatology, namely dermatitis, skin pigmentation diseases; ophthalmology; ocular disorders; gastroenterology; and gynecology, namely pelvic, urological and reproductive system diseases, disorders and infections, sexually transmitted diseases, sexual dysfunction, infertility and incontinence. Pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; smoking cessation preparations; pharmaceutical preparations for the treatment of tissue injuries, diseases and disorders; acne medication; allergy medication; antacids; anthelmintics; antiarrhythmics; antibiotics; anticoagulants; anticonvulsants; antidepressants; antiemetics; antiflatulants; antihistamines; antihypertensives; anti-infectives; anti-inflammatories; antiparasitics; antibacterials; antifungals; antivirals; burn relief medication; calcium channel blockers; central nervous system depressants; central nervous system stimulants; cough treatment medication; diarrhea medication; gastrointestinal medication; pharmaceutical preparations for the treatment of glaucoma; hydrocortisone; sedatives; and ophthalmic preparations. .